MAIA Biotechnology Inc. (MAIA)
MAIA Biotechnology Presents Trial in Progress Poster for Pivotal Phase 3 Clinical Trial of Novel Telomere Targeting Agent at 2026 Annual Meeting of American Society of Clinical Oncology
MAIA Biotechnology Presents Trial in Progress Poster for Pivotal Phase 3 Clinical Trial of Novel Telomere Targeting Agent at 2026 Annual Meeting of American Society of Clinical Oncology
Rocket Mortgage, Nation’s #1 Mortgage Lender, Adopts VantageScore 4.0 Credit Score for Mortgages
Palladyne AI Appoints Retired Lieutenant General Sean Bernabe and Retired Brigadier General Gwyn Armfield to Defense Advisory Board
WD at Computex 2026: AI Doesnt Just Run on Compute - It Runs on Data
Shake Shack to Participate in June Investor Conferences
See Alpha and Omega Semiconductor at PCIM 2026 to Learn About Their Advanced AI Core Power, AI Data Center, and Industrial Power Solutions
Optimum Subsidiary Announces Launch of Tender Offer for Shares of Optimum’s Class A Common Stock
UL Solutions to Attend Upcoming Investor Conferences
Optimum Launches Effort to Drive a Consensual Repositioning of its Capital Structure
Vertex Announces US FDA Acceptance of Biologics License Application for Accelerated Approval of Povetacicept in IgA Nephropathy